Exagen Inc.
XGNDiagnostics & Research
$8.70+3.57%As of Oct 29vs prior close
- Market cap
- $210.8M
- P/E (TTM)
- –
- From 52W high
- −26.58%
- EPS (LTM)
- -$0.82
- Revenue (LTM)
- $71.1M
- Net margin
- -26.61%
- Dividend yield
- 0.00%
Nomior Score
25
Steady ProfileSpeculativeBottom 10% of the scored universe
Growth58
Quality20
Value38
Momentum33
Resilience32
Growth
+10.82%revenue a year over 7 fiscal years
YE18 $32.4MLTM $71.1M
Connections
Revenue to profitQ2 YE26
The operating loss was 9% of revenue, narrower by 7 pts on a year.
Who owns it
1fund, 1 tracked portfolio